Telecommunication networks are growing exponentially due to their significant role in civilization and industry. As a result of this very significant role, diverse applications have been appeared, which require secured links for data transmission. However, Internet-of-Things (IoT) devices are a substantial field that utilizes the wireless communication infrastructure.
View Article and Find Full Text PDFPurpose: Children with relapsed/refractory central nervous system (CNS) tumors require novel combinations of therapies. Irinotecan and temozolomide (IT) is a frequently used therapy with an established toxicity profile. Bevacizumab is an anti-VEGF monoclonal antibody with demonstrated activity in CNS tumors.
View Article and Find Full Text PDFImportance: Although effective agents are available to prevent painful vaso-occlusive episodes of sickle cell disease (SCD), there are no disease-modifying therapies for ongoing painful vaso-occlusive episodes; treatment remains supportive. A previous phase 3 trial of poloxamer 188 reported shortened duration of painful vaso-occlusive episodes in SCD, particularly in children and participants treated with hydroxyurea.
Objective: To reassess the efficacy of poloxamer 188 for vaso-occlusive episodes.